K Ogurtsova1, J D da Rocha Fernandes2, Y Huang3, U Linnenkamp1, L Guariguata4, N H Cho5, D Cavan6, J E Shaw7, L E Makaroff8. 1. International Diabetes Federation, Chaussee de la Hulpe 166, Brussels, Belgium. 2. International Diabetes Federation, Chaussee de la Hulpe 166, Brussels, Belgium. Electronic address: joao.fernandes@idf.org. 3. International Diabetes Federation, Chaussee de la Hulpe 166, Brussels, Belgium. Electronic address: yadi.huang@idf.org. 4. International Diabetes Federation, Chaussee de la Hulpe 166, Brussels, Belgium. Electronic address: leonor.guariguata@gmail.com. 5. International Diabetes Federation, Chaussee de la Hulpe 166, Brussels, Belgium; Department of Preventive Medicine, Ajou University School of Medicine, 164 World Cup-ro, Suwon, South Korea. Electronic address: chnaha@ajou.ac.kr. 6. International Diabetes Federation, Chaussee de la Hulpe 166, Brussels, Belgium. Electronic address: davidcavan@hotmail.com. 7. Baker Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, Australia. Electronic address: jonathan.shaw@bakeridi.edu.au. 8. International Diabetes Federation, Chaussee de la Hulpe 166, Brussels, Belgium; Department of Microbiology and Immunology, University of Leuven, Herestraat 49, Leuven, Belgium. Electronic address: atlas@idf.org.
Abstract
AIM: To produce current estimates of the national, regional and global impact of diabetes for 2015 and 2040. METHODS: A systematic literature review was conducted to identify data sources on the prevalence of diabetes from studies conducted in the period from 1990 to 2015. An analytic hierarchy process was used to select the most appropriate studies for each country, and estimates for countries without data were modelled using extrapolation from similar countries that had available data. A logistic regression model was used to generate smoothed age-specific estimates, which were applied to UN population estimates. RESULTS: 540 data sources were reviewed, of which 196 sources from 111 countries were selected. In 2015 it was estimated that there were 415 million (uncertainty interval: 340-536 million) people with diabetes aged 20-79years, 5.0 million deaths attributable to diabetes, and the total global health expenditure due to diabetes was estimated at 673 billion US dollars. Three quarters (75%) of those with diabetes were living in low- and middle-income countries. The number of people with diabetes aged 20-79years was predicted to rise to 642 million (uncertainty interval: 521-829 million) by 2040. CONCLUSION: Diabetes prevalence, deaths attributable to diabetes, and health expenditure due to diabetes continue to rise across the globe with important social, financial and health system implications.
AIM: To produce current estimates of the national, regional and global impact of diabetes for 2015 and 2040. METHODS: A systematic literature review was conducted to identify data sources on the prevalence of diabetes from studies conducted in the period from 1990 to 2015. An analytic hierarchy process was used to select the most appropriate studies for each country, and estimates for countries without data were modelled using extrapolation from similar countries that had available data. A logistic regression model was used to generate smoothed age-specific estimates, which were applied to UN population estimates. RESULTS: 540 data sources were reviewed, of which 196 sources from 111 countries were selected. In 2015 it was estimated that there were 415 million (uncertainty interval: 340-536 million) people with diabetes aged 20-79years, 5.0 million deaths attributable to diabetes, and the total global health expenditure due to diabetes was estimated at 673 billion US dollars. Three quarters (75%) of those with diabetes were living in low- and middle-income countries. The number of people with diabetes aged 20-79years was predicted to rise to 642 million (uncertainty interval: 521-829 million) by 2040. CONCLUSION:Diabetes prevalence, deaths attributable to diabetes, and health expenditure due to diabetes continue to rise across the globe with important social, financial and health system implications.
Authors: João E Dos Santos Araujo; Fabrício Nunes Macedo; André Sales Barreto; Márcio R Viana Dos Santos; Angelo R Antoniolli; Lucindo J Quintans-Junior Journal: Rev Diabet Stud Date: 2019-04-19
Authors: Yoshihiko Tashiro; Qinghong Han; Yuying Tan; Norihiko Sugisawa; Jun Yamamoto; Hiroto Nishino; Sachiko Inubushi; Y U Sun; Guangwei Zhu; Hyein Lim; Takeshi Aoki; Masahiko Murakami; Michael Bouvet; Robert M Hoffman Journal: In Vivo Date: 2020 May-Jun Impact factor: 2.155
Authors: Lina Al Kury; Vadym Sydorenko; Manal M A Smail; Muhammad Anwar Qureshi; Anatoliy Shmygol; Murat Oz; Jaipaul Singh; Frank Christopher Howarth Journal: Mol Cell Biochem Date: 2018-01-09 Impact factor: 3.396
Authors: Haitao Liu; Emma M Lessieur; Aicha Saadane; Sarah I Lindstrom; Patricia R Taylor; Timothy S Kern Journal: Diabetologia Date: 2019-10-14 Impact factor: 10.122
Authors: Maxim Verboven; Lisa Van Ryckeghem; Jamal Belkhouribchia; Paul Dendale; Bert O Eijnde; Dominique Hansen; Virginie Bito Journal: Sports Med Date: 2019-02 Impact factor: 11.136